CAD 0.37
(-6.41%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -91.1 Million USD | 69.97% |
2022 | -429.49 Million USD | -11111.59% |
2021 | 3.9 Million USD | 102.51% |
2020 | -155.12 Million CAD | 28.11% |
2019 | -215.78 Million CAD | -879.61% |
2018 | -22.02 Million CAD | -223.68% |
2017 | -6.8 Million CAD | -684.78% |
2016 | -867.18 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -8.18 Million USD | 64.44% |
2024 Q1 | -23 Million USD | 61.74% |
2023 Q4 | -60.11 Million USD | -313.74% |
2023 Q1 | -33.75 Million USD | -83.4% |
2023 Q2 | -20.97 Million USD | 37.85% |
2023 Q3 | -14.52 Million USD | 30.73% |
2023 FY | -128.95 Million USD | 69.97% |
2022 Q3 | -409.09 Million CAD | -2524.02% |
2022 Q1 | -20.71 Million CAD | 5.03% |
2022 FY | -429.49 Million USD | -11111.59% |
2022 Q4 | -18.4 Million CAD | 95.5% |
2022 Q2 | 16.87 Million CAD | 181.46% |
2021 Q4 | -21.81 Million CAD | -128.68% |
2021 FY | 3.9 Million USD | 102.51% |
2021 Q3 | 76.07 Million CAD | 0.0% |
2020 FY | -155.12 Million CAD | 28.11% |
2019 FY | -215.78 Million CAD | -879.61% |
2018 FY | -22.02 Million CAD | -223.68% |
2017 FY | -6.8 Million CAD | -684.78% |
2016 FY | -867.18 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aurora Cannabis Inc. | -69.32 Million CAD | -31.41% |
Avicanna Inc. | -8.74 Million CAD | -941.988% |
Avant Brands Inc. | -5.07 Million CAD | -1696.864% |
Cardiol Therapeutics Inc. | -28.12 Million CAD | -223.877% |
Crescita Therapeutics Inc. | -1.98 Million CAD | -4487.16% |
Knight Therapeutics Inc. | -16.83 Million CAD | -441.14% |
MediPharm Labs Corp. | -13.08 Million CAD | -596.331% |
OrganiGram Holdings Inc. | -229.47 Million CAD | 60.301% |
Canopy Growth Corporation | -657.26 Million CAD | 86.139% |
Willow Biosciences Inc. | -13.02 Million CAD | -599.217% |
Auxly Cannabis Group Inc. | -44.51 Million CAD | -104.671% |